AI assistant
Minerva Neurosciences, Inc. — Director's Dealing 2017
Jul 26, 2017
35086_dirs_2017-07-26_383541f5-74c3-4672-a2fa-d4a56b548b87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-07-24
Reporting Person: Vandervelpen Nico (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-24 | Stock Option (Right to Buy) | $4.71 | D | 25000 | Disposed | 2025-12-03 | Common Stock (25000) | Direct |
| 2017-07-24 | Stock Option (Right to Buy) | $4.71 | A | 25000 | Acquired | 2018-07-24 | Common Stock (25000) | Direct |
| 2017-07-24 | Stock Option (Right to Buy) | $10.20 | D | 12500 | Disposed | 2026-06-15 | Common Stock (12500) | Direct |
| 2017-07-24 | Stock Option (Right to Buy) | $10.20 | A | 12500 | Acquired | 2018-07-24 | Common Stock (12500) | Direct |
| 2017-07-24 | Stock Option (Right to Buy) | $10.00 | D | 12500 | Disposed | 2027-05-31 | Common Stock (12500) | Direct |
| 2017-07-24 | Stock Option (Right to Buy) | $10.00 | A | 12500 | Acquired | 2018-07-24 | Common Stock (12500) | Direct |
Footnotes
F1: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 4, 2015 and provides for vesting quarterly over 3 years beginning on December 4, 2015.
F2: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 16, 2016 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 16, 2016 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.
F3: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 1, 2017 and provides for vesting in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 1, 2017 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.